Document is current
Any future updates will be listed below
-
Authors
Ikegame, Satoshi
Siddiquey, Mohammed N. A.
Hung, Chuan-Tien https://orcid.org/0000-0001-6899-1312
Haas, Griffin
Brambilla, Luca https://orcid.org/0000-0002-5296-2426
Oguntuyo, Kasopefoluwa Y.
Kowdle, Shreyas https://orcid.org/0000-0002-7786-3547
Chiu, Hsin-Ping
Stevens, Christian S.
Vilardo, Ariel Esteban
Edelstein, Alexis
Perandones, Claudia
Kamil, Jeremy P. https://orcid.org/0000-0001-8422-7656
Lee, Benhur https://orcid.org/0000-0003-0760-1709
-
Funding
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (Post-doctoral Fellowship)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI07647, AI07647, AI123449, AI138921)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 25 May 2021
Accepted: 9 July 2021
First Online: 26 July 2021
Competing interests
: B.L., C.S., and K.Y.O. are named inventors on a patent filed by the Icahn School of Medicine, which includes the 293T-ACE2-TMPRSS2 (F8-2) cells used for the virus neutralization assay. J.P.K. is a consultant for BioNTech (advisory panel on coronavirus variants). The remaining authors declare no competing interests.
